secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elanco Animal Health Inc (ELAN)
CIK:        0001739104
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001104659-26-002723
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elanco to present at J.P. Morgan Healthcare Conference; no new material information disclosed
--------------------------------------------------------------------------------

- Presentation reiterates innovation, portfolio, productivity strategy, pipeline, financial outlook, and executive team insights from December Investor Day.
- No new financial guidance or specific metrics provided; 2025 outlook remains as of November 5, 2025, and reaffirmed December 9, 2025.
- Q4 2025 results expected to be announced in February 2026; no update in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739104/000110465926002723/0001104659-26-002723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739104/000110465926002723/tm262899d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-002723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer